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Abstract
Introduction: Obesity has become a major societal issue. Many researchers are looking for ways
to combat this growing epidemic. Brown adipose tissue (BAT) might be a way to help individuals
overcome the challenges associated with weight loss and maintenance of weight loss, but a better
understanding of BAT and how to control and utilize it is needed. BAT differs from white adipose
tissue (WAT) in that BAT is rich with mitochondria and therefore is metabolically active. BAT is
a source of non-shivering thermogenesis and can be activated both by cold exposure and
pharmacologically. Current methods of assessing BAT activity are invasive; a noninvasive method
to visualize BAT is highly desirable.
X-ray interferometry may be applicable to BAT imaging. Interferometry yields three
images from one acquisition: an absorption image, a dark-field (DF) image, and a phase contrast
image. The absorption image represents attenuation by the material, equivalent to conventional xray imaging; the phase contrast image shows refraction at interfaces through which the beam
travels. Small angle scatter caused by microscopic structures in the material cause the DF image;
DF has potential interest for BAT visualization. This study evaluated DF imaging as a means to
image BAT. The expectation was the large number of mitochondria in BAT will cause a large DF
signal, and furthermore that BAT activated by cold exposure would have a different DF signal
than BAT at normal conditions.
Materials and Methods: Mice were kept for one week at 8°C to activate BAT; control mice were
kept at 22°C. Biochemical markers were used to verify BAT activation by the cold exposure
regimen. DF images of cold-exposed and control mice were assessed visually and by region-ofinterest analysis to determine if activated BAT could be distinguished from tissue in the same
region in control mice. Absorption images provided the identification of an intrascapular region of
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interest for examination in the DF images. In vivo

99m

Tc-sestamibi SPECT was used as an

independent means to assess BAT activation.
Results: Biochemical markers showed that the cold exposure regimen caused activation of
intrascapular BAT as well as the beiging of inguinal WAT; only the intrascapular BAT region was
investigated by DF imaging. A region between the scapula and posterior to the spine was apparent
in both 8°C and 22°C mice; this region did not show substantial differences in DF signal between
the two groups, however. Region of interest analysis of the SPECT images showed increased
uptake in the intrascapular region for cold-exposed mice, but the increase was not substantial
enough to allow direct visual observation.
Conclusion: Both absorption and DF imaging were capable of contrasting BAT depots from
adjacent tissue in the intrascapular region. However, no significant difference in DF signal was
seen for this intrascapular BAT between the cold-exposed group and the mice kept at 22°C. This
indicated that BAT activation did not result in cellular changes, such as changes in cell size or
number of mitochondria, that would alter the small-angle scattering signal.
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Chapter 1. Introduction
This chapter provides the motivation for the project, reviews relevant background topics,
and states the hypothesis and specific aims.
1.1. Motivation
Obesity is a world-wide epidemic, with rates on the rise [Rodgers 2018]. Obesity is
associated with approximately 300,000 preventable deaths, $147 billion in medical costs, and $8.7
billion in lost worker productivity per year in the United States alone [Stein 2004; Finkelstein
2009; Ricci 2005].
Simplistically, obesity results from too much energy intake and not enough energy output
[Hossain 2007]. Methods to combat obesity focus on both sides of this balance. A number of
interventions are eﬀective for short-term weight loss, such as lifestyle changes and drug
interventions, but long-term maintenance of weight loss remains diﬃcult [Dombrowski 2014].
Bariatric surgery is eﬀective for long-term weight maintenance, but carries substantial risks and
expense compared to lifestyle changes and drug interventions; also, a range of obese individuals
are not eligible [Shah 2006]. There remains an urgent need to develop interventions that enable
eﬀective long-term weight loss maintenance. Fat-activating pharmacological agents hold promise
for promoting weight loss maintenance when paired with sustained reduction of energy intake
[Kang 2019].
Adipose tissue is a key component and principle target for interventional approaches.
Adipose tissue is found in a diverse array of organisms, formed at speciﬁc times and in speciﬁc
anatomical locations. Once considered a passive participant in the storage of energy, adipose tissue
is now recognized as a dynamic organ that performs several important physiological processes.
The increasing rates of obesity and obesity-associated pathologies across the globe underscore the
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importance of characterizing the weight-loss role of adipose tissue, especially brown adipose tissue
(BAT). This project assessed x-ray interferometry as a method for studying BAT.
1.2. Background
1.2.1. Brown Adipose Tissue
There are two distinct classes of adipose tissue: white adipose tissue (WAT) and brown
adipose tissue (BAT). WAT accounts for the majority of adipose tissue present in most mammals,
including adult humans, and it is a critical site for energy homeostasis, insulin signaling, and
endocrine action [Sarjeant 2012]. In contrast, BAT is responsible principally for nonshivering
thermogenesis, representing an enormous heat-generating capacity that is crucial in post-natal
babies and in a variety of hibernating mammals. Within the last 15 years, observations have
revealed that BAT depots can be present in the thoracic and supraclavicular regions of adult
humans [Cypress 2009; Nedergaard 2007]. BAT may be metabolically active [Zingaretti 2009],
and recent studies have shown that BAT is involved in diet-induced thermogenesis and wholebody fat utilization in healthy humans [Hibi 2016]. Cypess (2009) explains the function of BAT
as:
“The adipose-tissue pool in mammals is composed of at least two functionally different
types of fat: white and brown. White adipose tissue is the primary site of energy storage
and of release of hormones and cytokines that modulate whole-body metabolism and
insulin resistance. Excess accumulation of white adipose tissue causes obesity. Brown
adipose tissue, on the other hand, is important for both basal and inducible energy
expenditure in the form of thermogenesis mediated by the expression of the tissue specific
uncoupling protein 1 (UCP1). The mitochondria in BAT cells are able to us the UCP1 to
release energy as heat instead of creating ATP (Romu, 2018). BAT’s ability to use UCP1
for non-shivering thermogenesis is especially important for small and neonatal mammals
as they have a large ratio of surface area to muscle mass (Romu, 2018). Brown adipose
tissue affects whole-body metabolism and may alter insulin sensitivity and modify
susceptibility to weight gain.”
BAT is responsible for non-shivering thermogenesis. It is estimated that as little as 50 g of
BAT, when maximally stimulated, could account for up to 20% of daily energy expenditure in an
2

adult human [Rothwell 1983]. If methods can be developed to increase the number of brown
adipocytes and to keep them constantly activated, then BAT may be a viable tool in the fight
against obesity [Cannon 2003].
The failure of long term weight loss maintenance is multiply determined, with inadequate
adherence to diet and exercise regimens, compensatory food intake in response to increased energy
expenditure, and metabolic adaptation all pushing individuals toward energy surplus [Stubbs 2004;
King 2007]. Efforts to increase adherence and prevent compensatory food intake remain important
and are ongoing.
Meanwhile, fat-activating agents have emerged as a powerful tool to combat metabolic
adaptation. These pharmacological agents increase adipose tissue energy expenditure, either by
increasing classical nonshivering thermogenic activity within the more metabolically-active BAT,
defined by the characteristic expression of UCP1; or they induce de novo UCP1 expression and
thus thermogenic activity within WAT, creating metabolically-enhanced ”beige” or ”brite” cells.
Evidence [Orava 2013] suggests that by increasing energy expenditure, fat activation could reduce
the dependency of weight loss maintenance on adherence to high levels of exercise, defined as
greater than 250 minutes per week [Donnelly 2009], that are difficult to maintain but are required
to overcome metabolic adaptation. Cold exposure and a variety of pharmacological agents
including β3-adrenergic receptor (β3-AR) agonists, FGF21, irisin, orexin, various natriuretic
peptides, and SIRT1 increase UCP1 expression in rodent fat (Harms & Seale, 2013), but translation
to human subjects has been slow [Baak 2002; Wouter 2009].
Figure 1.1 highlights the differences between BAT, WAT and activated beige adipocytes.
A giant lipid droplet makes up the majority of the cell body of WAT. WAT has very few
mitochondria. In contrast, BAT has only small lipid droplets and a large number of mitochondria.
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Beige adipose tissue (activated WAT) is a middle ground between WAT and BAT, with larger
lipid droplets than BAT and more mitochondria then WAT. The mitochondrial content plays an
important role in BAT and beige cells, correlating to the amount of UCP1 expression [Kazak
2017].

Figure 1.1. Comparison of white, beige and brown adipocytes, showing relative amounts
of lipid and mitochondria. (Illustration by J. Stephens)
1.2.2. Current Methods of Imaging BAT
The usual methods for quantitatively measuring BAT are invasive, such as biopsy followed
by assay of biochemical markers (mRNA, UCP-1) and histology. There is currently no imaging
method that is highly specific for BAT. The available imaging modalities vary substantially in
sensitivity, also. Positron emission tomography (PET) is the current standard for imaging of BAT
4

[Chen 2016]; the presence of BAT in adult humans was discovered as an incidental finding in PET
scans [Hany 2002; Cohade 2003]. PET imaging has found the most success using
fluorodeoxyglucose (FDG) as the radiopharmaceutical. The problem that lies with this mode of
imaging BAT is that the body sees FDG like sugar, therefore it isn’t specifically absorbed in BAT
but is dispersed throughout the whole body. SPECT has also been found as a viable method to
image BAT.

99m

Tc-methoxyisobutylisonitrile (99mTc-MIBI or

99m

Tc-sestamibi) is a radiotracer

known to accumulate in BAT [Goetze 2008], but is still generally dispersed throughout the body.
MRI has been shown to identify BAT, but only works with certain imaging sequences [Gashi
2019]. These methods are all viable options for imaging BAT but no one method stands out as the
best choice. This project assesses the potential of x-ray interferometry for BAT imaging, in
comparison to 99mTc-sestamibi SPECT and biochemical markers.
1.2.3. SPECT
Nuclear medicine imaging is a form of functional imaging. Functional imaging is a type of
imaging that shows physiological conditions, rather than traditional x-ray imaging that shows
anatomical structures. There are two steps to acquiring a nuclear medicine image: first, injecting
the subject with a radioactive compound that distributes within the body; second, acquiring planar
images [Bushberg 2012]. Planar images can be viewed directly, or they can be combined by a
reconstruction algorithm into a tomography data set. The two types of nuclear medicine
tomography imaging are single photon emission computed tomography (SPECT) and positron
emission tomography (PET), which differ by the types of radionuclides used and the designs of
the imaging detector. SPECT is reviewed below; the reader is referred to Bushberg (2012) or other
textbooks for information about PET.
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Radiotracers, also called radiopharmaceuticals, comprise two components, a radionuclide
and a pharmaceutical. The radionuclide emits radiation that is detected by the imaging system. The
pharmaceutical is a physiologically-active compound that dictates where in the body the
radiotracer will accumulate [Dey 2020]. The compound is chosen to match the physiological
function that one wishes to visualize. Ponto (1998) outlined seven criteria as desirable
characteristics of radiotracers:
(a) The radionuclide must emit gamma radiation that is suitable in terms of both energy and
abundance for imaging;
(b) The half-life of the radionuclide should be sufficiently long to allow optimal localization
and imaging, but not unnecessarily long so that radiation dose is not excessive;
(c) The radionuclide should not have particulate emissions to minimize excess radiation dose;
(d) The radiotracer should be available with a high specific activity (radioactivity-to-mass
ratio), which allows the tracer to efficiently follow the desired physiologic function;
(e) The radiotracer should not have undesirable pharmacologic or toxic effects (no adverse
reactions);
(f) The radiotracer must have a biodistribution suitable for the physiologic target, with the
radiotracer ideally localizing only in the tissue of interest; and
(g) The radiotracer must be available at a reasonable cost.
These seven characteristics can act as a guideline for choosing the radiopharmaceutical for SPECT
imaging. The radiotracer is introduced into the body by injection, ingestion, inhalation, or other
means. After injection, the radiotracer distributes throughout the body during an uptake period;
this allows the tracer to accumulate in the physiologic process or tissue of interest, and potentially
clear from other tissues. After the uptake period, image acquisition can begin.
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A common radionuclide for SPECT imaging is technetium-99m (Tc-99m); Tc-99m has a
suitable half-life of 6.02 hrs for radiotracer synthesis and image acquisition, can be tagged to a
large variety of pharmaceuticals, has an emission energy (140 keV) that is well-suited for use with
gamma ray detectors, and is easily distributed as the daughter of longer-lived reactor-produced
Mo-99 [Cherry 2012].
A variety of radiotracers are available for routine use. Common applications include
cardiac imaging, cancer imaging, renal function, brain function, hepatic function, and many others.
Information about common radiotracers for SPECT is available in Bushberg (2012), Cherry,
Sorenson, and Phelps (2012), and elsewhere. Some radiotracers relevant to BAT imaging were
discussed in section 1.2.2.
For SPECT imaging, a gamma camera acquires two-dimensional projection images of the
radiotracer’s three-dimensional distribution within the patient. A gamma camera (Figure 1.2)
comprises a collimator, a detector such as scintillator and photomultiplier (PMT) array, and data
processing electronics. Gamma rays emitted from the radionuclide are detected and mapped into
an image representing the radionuclide distribution in the patient. The collimator defines the
mapping by allowing gamma rays to pass through only on specific paths; collimator designs
include parallel-hole (cf. Figure 1.2) and pinhole (Figure 1.3) geometries. Rather than a
scintillation detector (scintillator and PMT array), some gamma cameras utilize solid-state
pixelated cadmium-zinc telluride detectors, which allows for better detection efficiency from a
more compact imaging system. Additional details on gamma camera design and operation are
available in Bushberg (2012), Cherry, Sorenson, and Phelps (2012), and elsewhere.
For SPECT, projection images are acquired at multiple detector orientations around the
patient, typically multiple views acquired along a circular orbit across a 180 or 360 range. Each
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projection image shows the radiotracer distribution from a unique perspective. These projection
images are put through a reconstruction algorithm to generate a three-dimensional rendering of the
radiotracer distribution in the patient [Bushberg, 2012]. Reconstruction algorithms for SPECT
generally are iterative reconstruction algorithms. SPECT image quality is affected by acquisition
parameters such as collimator type, acquisition time per projection, injected activity of radiotracer,
and number of projections and angular step size, as well as by the choice of reconstruction
algorithm. Detailed information about reconstruction is available in the literature.

Figure 1.2 Illustration of a gamma camera’s components (left). Gamma rays (red arrows)
are detected and mapped into an image of the radiotracer distribution (right), in this
case showing Tc-99m methylene diphosphonate accumulation in bones and cancer
(e.g., bright spot in lumbar spine). (Illustration by K. Matthews)
SPECT visualizes the physiological behavior of the radiotracer, such as shown in Figure
1.4. Anatomical references may be lacking, which is typically addressed by combining the SPECT
images with another modality, such as x-ray computed tomography (CT), to show the
corresponding anatomical information. With a dual modality SPECT-CT, a CT image is acquired
sequentially with the SPECT image acquisition. The subject doesn’t change position between the
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CT and SPECT acquisitions, allowing the two images to be overlaid for display. SPECT-CT
provides anatomical and physiological data at the same time, facilitating interpretation.

Figure 1.3. Illustration of a pinhole collimator. A pinhole collimator provides better spatial
resolution than other collimator geometries because of magnification effects. This
is the type of collimator used in this work. From (Bushberg 2012).

Figure 1.4. (left) SPECT image of Tc-99m sestamibi accumulation in a mouse. (right) Codisplay of SPECT-CT images. The CT anatomical reference facilitates interpreting
the location of elevated uptake (green arrows) as the bowels.
1.2.4. X-ray Interferometry
X-ray interferometry is a radiation measurement technique that extends x-ray detection
beyond the traditional absorption measurement. Traditional absorption measurements treat the xrays as individual quanta, measuring changes in transmitted intensity. X-ray interferometry utilizes
the electromagnetic wave properties of light, characterizing the radiation beam in terms of
frequency, phase, and amplitude. This yields three types of images: a traditional absorption image,
a differential phase contrast (DPC) image, and a dark field (DF) image. The absorption image
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measures differences in attenuation between tissues; absorption depends on the composition of
materials. For the polychromatic, keV-energy, broad-beam sources typically used for diagnostic
x-ray imaging, small differences in attenuation are difficult to visualize. Absorption images are
good for showing skeletal structure vs. air or soft tissue, for instance, but has poor contrast between
soft tissues. The DPC image is due to refraction at interfaces. DPC images thus are good for
showing boundaries between different tissues, even if those tissues don’t exhibit much inherent
radiographic contrast. The DF image quantifies the composite effect of small-angle scattering from
sub-micron structures within the tissue; this scattering process is below the resolution limit of
traditional absorption imaging methods, i.e., tissues that would appear homogeneous in a
traditional absorption image can exhibit a strong DF signal.
The acquisition geometry for Talbot-Lau interferometry, a common implementation for xray interferometry, is illustrated in Figure 1.5(a); Talbot-Lau geometry adds three x-ray gratings
to the combination of x-ray source, object, and detector used for traditional x-ray imaging [Pfeiffer
2009]. Other interferometer geometries differ from Talbot-Lau in the types and arrangement of the
gratings [Miao 2015, Wen 2008].
The concept for x-ray interferometry imaging is illustrated in Figure 1.5(b). The G0
grating (not shown, but located upstream of the object and G1) is a series of transmitting slits that
imposes coherence on the x-ray beam. The G0 grating enables the use a conventional large-focal
spot x-ray sources for interferometry [Pfeiffer 2009]. The G1 grating imposes a periodic phase
modulation on the x-ray beam, which takes on a distinctive “Talbot carpet” pattern that changes
with distance from the grating, as shown in Figure 1.6 [Wen 2013], The Talbot carpet is perturbed
further by interference effects caused by x-ray interactions in the object; this is illustrated by the
squiggly line just to the left of G2 in Figure 1.5(b). If this interference pattern illuminated a
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pixelated detector, each pixel would sample a portion of the pattern. However, even modern
pixelated detectors don’t have sufficient spatial resolution to directly measure pattern; even if they
did, one still could not separate the x-ray intensity measured by the detector pixel into the
contributions of the object versus that from the G1 phase modulation.
Separating the object’s contribution from G1’s contribution requires an additional grating
and repeated measurements of the interference pattern. This process is called stepped-grating
interferometry [Pfeiffer 2009]; the reader is referred to the literature for other acquisition methods,
such as “one-shot” [Bevins 2012; Kagias 2016] and analyzer-less [Miao 2016; Miao 2015; Xu
2020] techniques. In the stepped grating method, the G2 “analyzer” grating partially blocks the
interference pattern of x-rays from reaching a portion of the detector pixel. The intensity of x-rays
reaching the pixel is reduced by an amount dictated by the portion of the pixel that is blocked.
Shifting or “stepping” the G2 grating slightly in the direction perpendicular to the x-ray beam
changes the blocked portion and the resulting x-ray intensity. Repeated shifts spanning one or a
few periods of the G2 grating impose an intensity modulation on the measurement of the
interference pattern by the detector pixel, shown in Figure 1.5(c).
The intensity modulation is decomposed to generate the absorption, DPC and DF images,
by reference to a white-field data set that is acquired without the object in place. The white-field
data measures the G1 phase modulation. The absorption image is recovered from the average
intensity of the modulation, labeled a0 in Figure 1.5(c), DPC is measured from the phase 1 of the
modulation, and DF is determined from reduction in amplitude a 1 relative to the G1 phase
modulation [Pfeiffer 2009]. Compared to traditional x-ray absorption imaging where a single
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Figure 1.5. X-ray grating interferometry. (a) Setup with a source grating G0, a phase
grating G1, and an analyzer grating G2. (b) Through the Talbot effect a linear
periodic fringe pattern is created behind G1 in the plane of G2. (c) Intensity
modulation is detected in a detector pixel when one of the gratings is scanned
along xg. A loss in the amplitude of the oscillation due to the scattering of x rays in
the specimen (degradation of the coherent wave front) can be used to extract images
with dark-field contrast. From (Pfeiffer et al., 2009).
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image is acquired, stepped grating interferometry requires multiple exposures with the grating
stepped between each. For tomography imaging, the stepped grating process must be repeated at
each projection angle. While in theory only one set of white-field data is required, in practice one
acquires several sets during a tomography acquisition (say, at every 20 th projection angle) to
compensate for variations in x-ray output, gantry rotational effects, or other real-world
imperfections. In addition, the use of polychromatic x-ray sources complicates the appearance of
the Talbot carpet; gratings are typically designed for the average energy of a filtered
bremsstrahlung spectrum.

Figure 1.6. The optical Talbot effect for monochromatic light, shown as a “Talbot carpet.”
On the left, light diffracts through the grating; this pattern is reproduced on the right
edge, one Talbot length away from the grating. At the midpoint, one sees an
inverted pattern. At regular fractions of the Talbot length, multiples of the pattern
are clearly seen. From (Wen, Zhang, &Xiao, 2013).
X-ray interferometry has been shown to provide better soft tissue contrast than traditional
x-ray imaging [Donath 2010]. Currently, diagnostic x-ray interferometry is being developed for
mammography, lung imaging, and other applications [Hellbach 2015; Yaroshenko 2016; Scherer
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2017]. Eggl et al (2015) showed that x-ray interferometry could visually distinguish BAT from
WAT in a neonatal mouse; newborn mice have large quantities of BAT. The expected image
contrast mechanism for BAT is small angle scattering from highly abundant mitochondria in BAT,
measured in a DF image. A potential challenge for the current project is the smaller amounts of
BAT and beige adipocytes expected in adult mice from the cold-adaptation process used here (see
Chapter 2), compared to neonates.
1.3. Hypothesis and Specific Aims
This project seeks to demonstrate that stepped grating interfereometry can identify and
quantify BAT and activated beige adipocytes in adult mice. A cold-adaptation regiment is used to
generate BAT and to activate WAT; the degree of activation is assessed by assay of biochemical
markers. X-ray interferometry will be compared to SPECT imaging of

99m

Tc-sestamibi, a

radiotracer expected to have high uptake in BAT.
1.3.1. Hypothesis
The hypothesis of this work is that x-ray interferometry will show significantly elevated
DF signal at the expected location of BAT depots in cold-adapted mice. Further, the elevated DF
signal will correlate strongly to the biochemical assay results and to accumulation of

99m

Tc-

sestamibi measured with SPECT.
1.3.2. Specific Aims
1. Acquire whole-body radiotracer images of cold-exposed and control mice to localize the
BAT depots. SPECT-CT imaging with

99m

Tc-sestamibi is used to identify areas of BAT

activity, based on physiological accumulation of tracer in the BAT depots.
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2. Acquire whole-body x-ray interferometry images of cold-exposed and control mice, as well
as interferometry measurements of isolated BAT samples. The isolated BAT samples are
used for tuning/optimization of the interferometry acquisition procedure.
3. Correlate the Aim 2 results to the Aim 1 results and to biochemical assay results. Strong
agreement indicates that non-invasive x-ray interferometry is a viable tool for
quantiﬁcation and localization of BAT depots.
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Chapter 2. BAT Activation and Biochemical Markers
This chapter describes the cold-adaptation procedure used to activate BAT in adult mice,
and the measurement of biochemical markers to verify the procedure. The work described in this
chapter was performed by staff from the Adipocyte Biology lab at Pennington Biomedical
Research Center (PBRC), using facilities in the Comparative Biology Core lab. These activities
followed a protocol approved by the IACUC committee at PBRC and also by the IACUC
committee at the LSU School of Veterinary Medicine (see Appendix F).
2.1. Methods and Materials
The mice used in this study were C57BL/6 mice (PBRC breeding colony). This mouse
model is widely used to study metabolic health and obesity. Both male and female mice were
assessed. The experimental group of mice were cold-exposed to induce BAT activation, as
described in the next section. A control group of mice were maintained at 22°C, in otherwise
equivalent conditions.
2.1.1. Cold Exposure Regimen
Cold exposure elicits a wide range of fat activation in BAT and WAT in C57BL/6 mice.
Recent studies have shown that mice exposed to 4°C for 4 hours three times per week had a
substantial induction of BAT [Wang 2014]. Rather than using intermittent cold exposure, the
protocol for this study used a one-week chronic exposure at a higher temper of 8°C; this method
is routinely used at PBRC, resulting in thermogenic activation of BAT as well as the transition of
subcutaneous WAT into brown-like adipose tissue [Lim 2012].
The mice arrived at PBRC at approximately seven weeks of age. The mice were
quarantined for one week, as part of PBRC’s established procedures. Mice are normally housed
communally because they are social animals; isolation can be stressful to mice. However, isolation
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was necessary during cold-exposure to prevent group huddling as a strategy to maintain core
temperature, which could oppose BAT activation. The quarantine period was used to allow the
mice to adjust to solitary housing.
The cold exposure protocol placed individual mice in an environmental chamber set to
8°C; the mice were kept in standard plastic cages with bedding and access to food and water. The
control mice were placed in identical conditions, but at a temperature of 22°C. Mice were
maintained at the respective environmental temperatures for one week. The body temperature and
weight of the mice were monitored twice a day, to insure that the mice remained healthy; a drop
in core temperature below 30°C was grounds for removing the mouse from the protocol. At the
end of the exposure period, mice proceeded either to biochemical marker assay (section 2.1.2) or
to SPECT-CT and interferometry imaging (Chapter 3 and Chapter 4, respectively).
2.1.2. Biochemical Marker Assays
Assay of several biochemical markers that indicate BAT activation were used to assess the
effectiveness of the cold exposure protocol. Twenty mice of each sex were euthanized after one
week of cold-exposure at 8°C (n=17) or maintenance at 22°C (n=3). Euthanasia occurred
immediately after removal from cold exposure for most of the 8°C mice. In a subset of animals,
euthanasia was delayed by several hours to assess the stability of BAT activity in the first hours
after the end of cold exposure; this was important to show that the time needed to transport the
mice from PBRC to the SPECT imaging lab at the LSU School of Veterinary Medicine would not
impact the level of BAT activation. Several tissues representing both BAT and inguinal WAT
(iWAT) were removed and assayed for the expression of 8 genetic markers known to be correlated
with BAT activity (Table 2.1). The assays were performed by staff of the PBRC Comparative
Biology Core; these assays are among the repertoire of analyses available to PBRC researchers.
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Finally, H&E stained microscopy images were obtained for sections of sampled tissues to visually
compare BAT and iWAT between the cold-exposed and control groups.
Table 2.1. Biochemical markers used to assess BAT activation following one week of cold
exposure at 8°C.
Marker
UCP-1
PGC1a
CideA
Adrb3
C/EBPb
Cpt1b
Dio2
Elovl3

Notes
Located in the inner mitochondrial membrane and activation of UCPs leads to
the extrication or “stealing” of protons away from ATP synthase and ATP
synthesis. [Conn 2013]
Transcriptional coactivator that regulates the genes involved in energy
metabolism.
Essential transcriptional coactivator regulating mammary gland secretion of
milk lipids.
Located mainly in adipose tissue and is involved in the regulation of lipolysis
and thermogenesis.
Capable of increasing the expression of several target genes.
Highly expressed in heart and skeletal muscle cells and brown adipose cells.
Highly expressed in the thyroid.
An important component for early onset of lipid recruitment in brown adipose
tissue.

2.2. Biochemical Marker Results
Figure 2.1 compares gene expression between cold-exposed and control groups for both
sexes. The expressions of UCP1 and Elovl3 were significantly increased in BAT for both male
and female mice; given that UCP1 is closely tied to BAT activity, this result indicates that the
cold-exposure regimen is successfully increasing BAT activity. Cold-exposed female mice
exhibited a qualitative increase in expression for the other 6 markers, although only Dio2 changed
significantly; in male mice, the changes in the other 6 markers was mixed. In iWAT for both male
and female mice, gene expression was qualitatively consistently higher in the cold-exposed group
for all markers except Adrb3; however, only UCP1, Cpt1b, and Elov13 in males showed statistical
significance. The relative increase for all markers appeared larger for males than females.
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Figure 2.2 compares H&E stained histology images of BAT and iWAT, for both sexes, for
cold-exposed and control groups. H&E staining gives the cell walls a pink-purple hue while lipid
droplets appear as white. BAT cells are clearly smaller in size than iWAT; the large lipid droplets
in an iWAT are readily apparent. Cold-exposure causes little visual change in BAT for either sex.
By comparison, iWAT in cold-exposed animals appear to have smaller lipid droplet sizes, which
is consistent with beiging of WAT and consumption of lipid.
The results in Figure 2.1 indicate that the cold exposure regimen successfully caused
activation of BAT to a significant degree. These results are consistent with data presented by Zhang
(2017). Further, the iWAT results in Figure 2.1 and Figure 2.2 show that iWAT is likely becoming
beiged, potentially at a significant level in male mice. The beiging of WAT is important because
the intrascapular BAT depots that were targeted for DF imaging (see Chapter 4) likely exhibit a
mixture of BAT and WAT cells; both activated BAT and beige WAT thus should contribute to DF
signal. Because the increase in UCP1 collectively for BAT and iWAT was larger in male mice
than in females, the imaging studies were performed with male mice.
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Figure 2.1. Comparison of gene expression in BAT (top) and iWAT (bottom) between
cold-exposed and control groups for both sexes. Genes exhibiting significant
changes due to cold exposure are marked with * (p<0.05), ** (p<0.01), ***
(p<0.001), and **** (p<0.0001).
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Figure 2.2. H&E stained tissue sections of BAT and iWAT for cold-exposed and control
mice. Three samples are shown for each sex. The magnification was 10x. BAT
cells are 10-25 um in diameter; WAT cells are 50-200 um in diameter.
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Chapter 3. Aim 1 SPECT
This chapter discusses SPECT-CT imaging of BAT in mice using

99m

Tc-sestamibi. The

goal of the SPECT-CT imaging was to have an independent visualization of the location of the
BAT deposits, ensuring that the correct anatomical region was being evaluated by DF imaging
(Chapter 4). A secondary goal was that radiotracer uptake would provide additional verification of
BAT activation in conjunction with the biochemical assay results. A first group of mice were used
to refine the procedure for SPECT-CT imaging of BAT; this procedure was then used on a second
cohort of mice to acquire data for comparison to DF imaging.
3.1. SPECT-CT System
SPECT-CT utilized a Triumph II SPECT/CT scanner (Trifoil Imaging) located in the Small
Animal Imaging Laboratory at the LSU School of Veterinary Medicine (SVM). Shown in Figure
3.1, this system provides both SPECT and CT acquisition hardware on a single gantry. Shielding
built into the system cabinet provides radiation protection for the operator. The Triumph II includes
an onboard gas anesthesia system as well as a heating coil built into the imaging table. Both
camera-based visual monitoring and pneumatic respiratory monitoring are available.
The CT subsystem uses a microfocus x-ray source with a CMOS-based flat-panel x-ray
detector. The detector has 2240x2368 pixels with a 50 m pitch. The operating range of the xray source is 40-80 kV. The source and detector move relative to the imaging bed to provide a
range of magnifications. Vendor software provides detector uniformity correction.
The SPECT subsystem supports up to 4 cameras; only one camera is installed in the SVM
system. The camera is a solid-state CZT detector with 80x80 pixels spanning a 12.7-cm x 12.7-cm
field of view; the detector pixels are 1.5 mm in size. The vendor quotes an energy resolution of
4.6%. Several types of collimators are available: parallel-hole, single-pinhole, and multiple22

pinhole; this work used the N1F90A10 single pinhole collimator with 1-mm pinhole and 90-mm
focal length. Vendor software provides energy and uniformity calibrations, which are required for
each combination of radionuclide and collimator that are used.

Figure 3.1. Photograph of the Triumph II SPECT/CT system located in the Small Animal
Imaging Laboratory of the LSU School of Veterinary Medicine.
3.2. SPECT Imaging Procedure
The SPECT image acquisition procedure is described in this section. Because this was a
pilot study, refinements were made to the initial procedure based on the experience of the first few
mice that were imaged. The refined plan was then used for subsequent animals. The basic SPECT
imaging procedure was:
1. Transport a mouse from PBRC to the Small Animal Imaging lab at SVM;
2. Inject 99mTc-sestamibi, followed by an uptake period;
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3. Acquire CT and SPECT images of the anesthetized mouse; and
4. Euthanize the mouse and store the carcass for 3 days to allow for radioactive decay.
After the storage period, the non-radioactive carcass was transported to the x-ray interferometry
system for DF imaging. Details related to each step are described in the following subsections.
3.2.1. Transportation
On the day of imaging, the mice were removed from the temperature-controlled exposure
chambers and placed in approved transportation cages. The mice were driven from PBRC to SVM
in groups of two or three per day for imaging. The combination of transport time, the delay until
injection for the later animals, and the uptake period meant that cold exposed mice could be out of
the cold environment for up to several hours before injection. To minimize the chance of reduction
in BAT activity during this time, ice packs were kept around the cages during transport, while
waiting prior to injection, and during uptake.
3.2.2. Injection Procedure
99m

Tc-sestamibi is a radiotracer that follows mitochondrial activity, which is pertinent to

BAT imaging. In humans, clearance from the blood is very rapid and accumulation is typically
seen in the heart, liver, and thyroid and parathyroid; excretion is through the biliary system into
the intestine [Cardinal Health 414, LLC 2016]. This tracer has been reported to accumulate in BAT
in humans [Bauwens 2014; Goetze 2008]. It was chosen for this project specifically because it
reportedly has higher uptake in BAT than many other tracers [Baba 2007]. The

99m

Tc-sestamibi

radiotracer (Cardinal Health) was received each morning as a single 20 mCi dose in a volume of
0.5-1 mL saline. The radiotracer was transferred into 0.3 mL 29 ga. insulin syringes, one for each
mouse. The amount transferred was such that radioactive decay would result in approximately 1
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mCi at the estimated time of injection; solution volumes ranged from 40-100 L because of
variations in the initial volume.
Just prior to injection, the mouse was anesthetized with isoflurane while the radiotracer in
the insulin syringe was warmed for a few moments in a 38°C water bath. These initial steps were
implemented after several of the 8°C mice died during tracer injection; in consultation with the
veterinarians at PBRC and SVM, it was hypothesized that the cold-exposed mice could be less
compliant to the stress of injection, especially with a fluid that was much cooler than body
temperature. The mouse was placed in a cylindrical immobilizer with the tail sticking out from the
end (Figure 3.2). A piece of wet warm gauze (from immersion in the water bath) and gentle
palpation was used to expand the tail vein, through which the radiotracer was then injected. The
syringe was assayed before and after injection in a dose calibrator (Capintec CRC-55tW, Mirion
Technologies) to determine the net injected activity.
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Figure 3.2. Mouse holder for tail vein injections. The mouse is placed in the cylinder with
the tail extending through a slot in the bottom end. The plunger is pushed into the
cylinder until the mouse is gently compressed and cannot move around.
One question to address was the length of the radiotracer uptake period prior to SPECT
imaging. To determine this, sequential planar images were acquired to elucidate the temporal
kinetics of

99m

Tc-sestamibi in two cold-exposed mice and one control mice. Each mouse was

anesthetized, injected with 99mTc-MIBI, and then immediately put into the SPECT scanner. Planar
images were acquired for a posterior view of the mouse with the single-pinhole collimator
(N1F90A10) for 30 frames at 5 minutes per frame. The camera radius of rotation was 55 mm for
one 8°C mouse to cover the whole body, while a radius of 35 mm was used for the second 8°C
mouse and the 22°C mouse for higher magnification of the region from mid-skull to base of tail.
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Region of interest analysis on the sequential planar images identified the time point after injection
when uptake in the region between the scapula, where BAT is expected to be found, was generally
highest.
3.2.3. SPECT-CT Acquisition
To start a SPECT-CT acquisition, the mouse was first anesthetized with isoflurane. The
mouse was positioned prone on a Styrofoam pad on top of the imaging bed, with the hind legs and
tail held in place by adhesive tape. Figure 3.3 shows a mouse positioned for imaging. The mouse’s
nose was placed a slit in a latex membrane that covered the anesthesia cone; this cone delivered
isoflurane to the mouse while directing exhaled and excess isoflurane out through an exhaust port.
A respiration sensor placed under the mouse’s abdomen and a camera mounted next to the
anesthesia cone provided monitoring of the animal. The target respiratory rate was 25 breaths per
minute, representing an appropriate level of anesthesia; anesthesia was maintained throughout the
SPECT-CT acquisition.
Once the mouse was positioned, a CT scan was acquired. Scan parameters were 75 kV,
512 projections at 230 ms exposure time per projection, and a magnification of 1.3 which yielded
an axial field of view of 91.1 mm; the CT detector was set to 2x2 binning. SPECT imaging was
then performed. The single pinhole collimator with 1 mm pinhole diameter (N1F90A10) was used;
pinhole collimator was used to provide higher spatial resolution than available with the other
collimator options. The exposure time per projection was 10 s with 64 projections acquired over
360°. The radius of rotation was 45 mm, for a 76 mm axial field of view.
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Figure 3.3. A mouse positioned on a Styrofoam pad on the imaging bed. The mouse’s nose
is placed in the anesthesia cone. The pressure sensor for respiratory monitoring is
located under the mouse’s stomach. (left) Side view of the mouse. (right) Top view,
with the monitoring camera visible to the upper left of the anesthesia cone.
After imaging, the animals were euthanized by an overdose of isoflurane followed by
cervical dislocation. The carcasses were stored in a freezer for at least 3 days to allow for
radioactive decay.
SPECT and CT data were reconstructed using software provided with the Triumph II
system. The SPECT images were reconstructed using an iterative algorithm. The CT images were
reconstructed using a frequency domain kurtosis (FDK) algorithm with 2x2 binning during
reconstruction to reduce calculation time and data file size. Neither vendor-provided
reconstruction software provided extensive details on its functions, nor many user-selectable
parameters.
Avizo 9.0.1 was used for analysis of the image data, including co-display of the SPECT
and CT images. SPECT data was normalized to the injected activity for each mouse. Volume
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renderings and overlays in Avizo allowed visual identification of anatomical regions where 99mTcMIBI accumulation was expected.
3.3. Initial Assessment of SPECT Results
Table 3.1 records the initial and residual activities in the syringe for each mouse along with
assay times, as well as the calculated decay-corrected net activity at the time of the start of SPECT
acquisition. To facilitate comparison between SPECT images, each data set was normalized to the
injected activity.
3.3.1. Length of Uptake Period
Time-activity curves (TACs) for

99m

Tc-sestamibi uptake in selected organs are compared

in Figure 3.4 for a cold-exposed mouse and a control mouse. Regions of interest were identified
on a composite (summed) image derived from the 30 5-minute planar images (see appendix A)
then applied to each frame. The TACs show that tracer uptake was elevated in the intrascapular
(BAT) region for the 8°C mouse compared to the 22°C mouse, indicating that the cold exposure
process did produce an increase in BAT activity. The BAT curve for the 8°C mouse increased
slowly over the first hour post-injection, then leveled off; the TAC for the corresponding region in
the control mouse was level over the acquisition period. From these TACs, a 1-hour uptake time
was chosen for SPECT imaging; this agrees with uptake times reported in the literature for this
tracer, such as Baba (2007).
Although not relevant to BAT assessment, other differences were noted. The TACs for the
heart showed that cardiac activity in the 8°C mouse was higher than that for the 22°C mouse;
increased cardiac activity is a reasonable adaptation for a cold-exposed mouse. The bladder TAC
was higher for the 8°C mouse compared to the control mouse, although accumulation of tracer in
the bladder was slower; higher kidney function would be consistent with increased cardiac
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function, although differences in urine output are probably attributable to differences in recent
fluid intake rather than an effect of cold exposure.

Table 3.1. List of all mice with cohort and mouse numbers, indicating the maintenance
temperature during the week-long exposure (8°C = cold-exposed, 22°C = control).
Activity measurements and associated time stamps are also provided. The activity
in each mouse at the start of SPECT imaging was used to normalize each SPECT
dataset.
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Figure 3.4. Plot of time-activity curves for 99mTc-sestamibi for regions of interest drawn
over the intrascapular region where BAT is expected, heart, bladder, and left
kidney. Curves for the 8°C mouse are solid lines; dashed lines represent the 22°C
mouse. Time 0 is the time of injection of tracer into each mouse.
3.3.2. Visual Assessment of Tc-99m Sestamibi Uptake in BAT in SPECT-CT Images
Figure 3.5 compares 3D renderings of the SPECT-CT images for representative coldexposed and control mice; the SPECT-CT images for all mice can be found in Appendix B. These
renderings used the same window and level setting for display of the SPECT data; the same CT
thresholds were used for each. The blue ovals in Figure 3.5 indicate the region where BAT would
be expected, posterior to the spine and between the scapula. Activated BAT in a cold-exposed
mouse should show higher 99mTc-MIBI uptake in this region, although no clear visual indication
of elevated uptake is observed.
The 8°C mouse shown in Figure 3.5 (right) exhibited spots of increased uptake in the region
just below the lower jaw. By comparison, the 22°C mouse exhibited only a generalized uptake in
this region. This may correspond to a supraclavicular and/or anterior cervical BAT deposit [Zhang
2018]. Perusal of the SPECT images in Appendix B shows that a subset of 8°C mice showed this
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focal uptake, with the remainder showing diffuse uptake, whereas the 22°C mice generally showed
only diffuse uptake, if any.

Figure 3.5. Mouse 4 (left) and Mouse 8 (right) from cohort 1; Mouse 4 was a control mouse
while Mouse 8 was a cold-exposed mouse. Blue ovals mark the regions between
scapula and posterior to spine where activated BAT is expected to be found. Most
of the anesthesia cone and the imaging table were cropped out of the images.
3.4. SPECT-CT Discussion
No substantial differences in MIBI uptake in the intrascapular BAT were visually apparent
between mice kept at 8ºC for a week and control mice that were kept at 22ºC, despite the TACs
showing higher uptake in this region. Small spots of focal uptake below the lower jaw in some 8°C
mice may be evidence of supraclavicular uptake. A likely reason for the lack of strong visual
evidence is that the uptake per voxel was not high enough compared to Poisson statistical
variations (a lack of signal to noise). Note that the TACs were determined by region of interest
analysis, which provides a better signal-to-noise ratio than a voxel-by-voxel comparison. An
improvement would be to one of the Triumph II’s other collimators rather the single pinhole
collimator. The parallel-hole collimator has higher sensitivity, as do the multi-pinhole collimators,
although at the expense of spatial resolution. A higher sensitivity may help with visual observation
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of higher uptake in the BAT deposit. From Figure 3.5, it appears that some reduction in spatial
resolution could likely be tolerated.
Another limitation may be the choice of radiotracer.

99m

Tc-sestamibi was chosen because

it follows mitochondrial activity, which is pertinent to the large amounts of mitochondria found in
BAT. MIBI is also available in a prepared injectable form; a tracer such as

123

I-

metaiodobenzylguanidine (MIBG) would have required on-site synthesis, which was not feasible
in this pilot study. While a tracer such as 18F-FDG exhibits substantial uptake in BAT [Baba 2007;
Bauwens 2014; Zhang 2018], the radiation emissions of F-18 cannot be imaged on the version of
the Triumph II scanner available at SVM. Baba (2007) showed that MIBI exhibited an increased
uptake in BAT in cold-exposed rats (a single 4-hr exposure at 4°C) compared to control; however,
they found that the increase was not statistically significant. Bauwens (2014) noted that increased
MIBI uptake could be due to increased blood flow in BAT. Future studies should consider using
another tracer such as 123I--methyl-p-iodophenyl-pentadecanoic acid(BMIPP) [Zhang 2018].
Another possible limitation is the potential inhibition of BAT-induced thermogenesis by
isoflurane [Olsen 2017]. Undesirable suppression of BAT activity by isoflurane could be avoided
by doing ex vivo imaging of the mice. After injection with tracer and waiting for uptake, the mice
could be euthanized, essentially stopping metabolic activity, and then imaged. While this would
have worked for this pilot study, ex vivo imaging would not be feasible for longitudinal studies
where the same animal is used for repeated imaging, such as to follow the time development of
BAT activation. Alternatives to isoflurane, such as pentobarbital or ketamine, could also be
considered.
It should be noted that the inability of 99mTc-sestamibi to visualize BAT activation, while
troublesome, does not invalidate the primary goal of assessing x-ray interferometry for BAT. The
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reason for radiotracer imaging in this pilot study was to provide an independent means of visually
illustrating the location of the BAT depots, providing confidence for assessing the correct regions
with interferometry. Fortunately, Zhang (2018) and other literature provides anatomical references
for BAT. A quantitative assessment of the

99m

Tc-sestamibi data is given in Chapter 5, in

comparison to the DF imaging results.
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Chapter 4. Aim 2 Interferometry
This chapter discusses the second aim of the project, which was to acquire x-ray dark-field
interferometry images of the mice, focusing of the region of the intrascapular BAT deposit.
4.1. W.M. Keck X-ray Interferometry Imaging System
A Talbot-Lau interferometry system was used for this project, shown in Figure 5.1, which
is located at PBRC. The development of this interferometer was funded by a grant from the W.M.
Keck Foundation. This system has a stationary gantry with a rotating sample stage; the rotation
axis is oriented vertically. The x-ray source is an UltraBright 96000 Microfocus source (Oxford
Instruments) with tungsten anode, operating at 10-90 kV, 13-20 m focal spot, and 2 mA max
beam current (10-80W max power). The G1 grating is configured with a piezoelectric stepper
motor to provide stepped-grating acquisitions (cf. Figure 1.5). The gratings were manufactured by
Microwerks GMBH to specifications provided by the LSU interferometry research team; the
gratings are curved to enable an approximately 5 cm wide field of view (L. Butler, private
communication). The detector is a 1512 CMOS Flat Panel Detector (Varex Imaging) flat panel xray detector with a 1944x1536 matrix and 74.8 m pixel size.
The system is controlled by a LabVIEW user interface with Python acquisition scripts, all
developed in-house. The software allows the user set acquisition parameters such as the x-ray
source kV and power, the number of projections, the number of grating steps per projection, the
exposure time of each image, and the frequency of white-field images. After an acquisition, an inhouse algorithm processes the stepped-grating images into interferograms; this algorithm is robust
with respect to grating defects (K. Ham, private communication). Sinograms are generated from
the interferograms, then reconstructed with the ASTRA toolbox on a Linux-based GPU system,
producing tomography datasets representing attenuation and DF.
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Figure 4.1.Photo of the Keck x-ray interferometry-tomography system. (A) X-ray source
housing; (B) source grating G0; (C) phase grating G1; (D) analyzer absorption
grating G2; (E) detector. Not visible is the rotation stage, located just downstream
of G1, that holds the sample.
4.2. Dark-Field Interferometry Methods
4.2.1. Sample Preparation
Unlike the imaging bed of the Triumph II system, the Keck system requires a vertical
orientation of the sample. To hold the mouse vertically, the sample holder shown in Figure 4.2
(left) was developed and used with the Cohort 1 mice. The holder was a 3.8 cm inner-diameter
acrylic cylinder glued to a base plate; the cylinder’s symmetry produced a consistent absorption
pattern to each projection, minimizing its contribution to the interferograms. The base plate
attached to the interferometer’s rotation stage. The mouse was oriented nose-down in the cylinder.
A rubber band secured the mouse’s pelvis to a plastic dowel; the dowel was hot-glued to the top
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of the cylinder. The tail was held in place by another rubber band, to ensure that the tail wouldn’t
collide with the fragile gratings.

Figure 4.2. (left) A Cohort 1 mouse positioned in the original sample holder. (right) A
Cohort 2 mouse suspended in the improved sample holder, which provided
improved specimen stability with a nose cone and access to secure a suture through
the abdomen.
After SPECT imaging, the carcasses were stored in a freezer for at least three days for
radioactive decay. The mice were kept frozen until put into the holder for interferometry imaging.
Unfortunately, the pendant geometry caused the mice to sag downwards as they thawed during
interferometry acquisition. Several strategies for improved immobilization were tried, including
allowing time for the mouse to thaw completely before imaging, and packing the cylinder with
37

material (e.g., Styrofoam beads or gauze). None of these strategies were wholly successful, and
could potentially add extraneous interferometric signal to the data.
Based on the experience with Cohort 1, the sample holder was modified and the method
for securing the mouse was improved, shown in Figure 4.2 (right). A polyethylene block with a
machined aperture was added to the bottom of the cylinder, to hold the mouse’s nose. Also, PBRC
colleagues suggested putting a suture through the mouse’s abdomen (T. Mendoza, private
communication), securing through two holes bored through the sides of the cylinder .
Another issue noted in the images from Cohort 1 was a large dark-field signal coming from
the fur of the mice (Figure 4.3). There was concern that the DF signal from hair was covering any
signal that might be coming from the BAT. To prevent the hair from interfering with the BAT
signal, the mice in Cohort 2 were shaved using barbering shears, from the base of the ears to the
apex of the spinal curve (Figure 4.4). The shaved area was larger than the expected size of the
intrascapular BAT depots.

Figure 4.3. DF projection image of an unshaved mouse, showing strong signal from hair.
The appearance of hair is unique to DF compared to traditional absorption imaging.
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Figure 4.4. Photograph of a mouse that was shaved around the neck region in
preparation for interferometry imaging.
Thus, the final procedure for sample preparation of Cohort 2 mice was:
1. The mouse was removed from the freezer and allowed to thaw for an hour at room
temperature. (Note: to see if freezing and thawing was affecting the DF signal, three mice
were euthanized directly after removal from cold-exposured, and immediately prepared for
interferometry imaging; this step was skipped for these mice. No SPECT imaging was
performed on these mice.)
2. The mouse was shaved from the base of the ears to the apex of the spine.
3. A suture was run across the belly of the mouse just under the skin.
4. The ends of the suture were fed through the two holes in the holder’s cylinder, as the mouse
was slid into the cylinder.
5. The mouse’s nose was placed the aperture at the bottom of the cylinder.
6. The mouse’s pelvis was secured to a plastic dowel with a rubber band. The dowel was hotglued to the top of the cylinder.
7. Finally the mouse’s front legs were restrained behind the suture and the suture’s ends were
tied tightly together around the outside of the cylinder.
These steps were performed to ensure the mouse didn’t slump downwards or otherwise move
during interferometry imaging. In all, each mouse of Cohort 2 was secured at three points: the
nose, the abdominal suture, and the hind legs.
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4.2.2. Interferometer Tuning
As discussed in Section 1.2.4, the distance between the object and G2 affects the
interferometric data quality, as do the x-ray energy, the periods of the gratings, and the distances
between the gratings. These parameters can be changed to tune the interferometer to be better at
measuring small angle scatter off certain size objects. This selection of object size is known as the
interferometer correlation length. In this work the interferometer was tuned to maximize the BAT
signal. These latter parameters were set by the grating designs. For Cohort 1, the choice of distance
was determined by visually comparing planar interferometry images of a mouse acquired at several
object-to-G2 distances. These DF projection images were visually compared to identify the image
with the strongest BAT signal compared to surrounding tissues; the corresponding distance was
used for Cohort 1 interferometry acquisitions.
For Cohort 2, the object-to-G2 distance was reassessed, this time using excised samples of
BAT and WAT samples. A PBRC colleague dissected a mouse and extracted samples from the
expected anatomic locations of the intrascapular BAT depot and an abdominal WAT depot. The
samples were placed in a microcentrifuge tube. DF projection images were acquired at various
object-to-G2 distances. Region of interest analysis of the images was used to select the distance
that exhibited the highest contrast between the BAT and WAT specimens.
4.2.3. Interferometry Acquisition Parameters
The mouse in the holder was placed on the rotation stage, which was aligned at the chosen
distance from the G2 grating. The height of the rotation stage was adjusted to insure to place the
intrascapular region near the center of the field of view. The x-ray tube was set to 50 kV and 50
W. Projection data were acquired every 1 over a 180° range. Images were obtained for 30 grating
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steps of 62 at each projection angle; the grating steps spanned approximately 2 fringe periods for
the curved gratings. The exposure time of each image was 3 seconds.
White field images were taken every 20°. For these white field images, the mouse was
lowered out of the field of view, images were taken for the 12 grating steps, then the sample was
raised back into position. Each set of white field images were used to convert the adjacent 20° of
interferograms into the absorption, DF, and phase contrast data.
Sinograms generated for the absorption and DF data were then reconstructed. For the best
image quality, an interactive reconstruction algorithm was used for the DF data; for speed, a
filtered backprojection algorithm was used for the absorption data. Analysis of the interferometrytomography datasets was performed using a combination of Avizo, Matlab, ImageJ, and Python.
4.3. Initial Assessment of Interferometry Results
4.3.1. Sample Preparation
The poor immobilization provided by the sample holder for Cohort 1 is illustrated in the
projection images shown in Figure 4.5. The mouse’s head was noticeably lower in the holder at
the later projection image, approximately 2 hours after acquisition began. This movement resulted
in severe artifacts in the 3D reconstructions of the absorption and DF images. Figure 4.6 shows
the improved sample stability obtained with the modified setup procedure for Cohort 2. The sample
showed no noticeable sag during the course of the acquisition; artifacts due to sample motion were
noticeably less in the 3D reconstructions.
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Figure 4.5. Absorption projection images of Mouse 2 Cohort 1. The left image is the
projection at 1, the right is at 180. These images should essentially be mirror
images of each other; the downward sag as the mouse thawed is readily apparent.
Figure 4.7 shows the impact of shaving the mice on the DF images. The difference in
appearance was substantial; the fur on the edges of the body shows a distinct pattern in the DF
image, with much the same appearance that fur has when viewed optically. The concern was that
this substantial signal could mask the weak DF signal from BAT in the middle of the mouse. The
appearance of fur or hair (or feathers or other very low-density finely detailed structure) is minimal
with absorption imaging; its appearance here highlights a key strength of dark-field imaging,
specifically how the DF signal results from a distinctly different physical process than attenuation.
This ability to see such detail was a primary motivation to evaluate DF imaging of BAT.
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Figure 4.6. Absorption projection images of Mouse 5 Cohort 2. The left image is the
projection at 1, the right is at 180. These images closely mirror each other,
showing the improved stability provided by the modified sample holder.

Figure 4.7. Projection images comparing the unshaved Mouse 2 Cohort 2 (left) to the
shaved Mouse 5 Cohort 2.
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4.3.2. Interferometer Tuning and Correlation Length
Figure 4.8 shows the location of the expected BAT depots in the intrascapular region; also
shown are excised WAT and BAT samples. The BAT exhibited a darker red color compared to
WAT, as expected [Baba 2007]. From the images at various object-to-G2 distances of the excised
BAT and WAT samples, a distance of 265 mm from the center of the rotation stage to the G2
grating provided the most contrast between BAT and WAT signals. Table 4.1 shows these BAT
and WAT signals and the ratios between them. This object-to-G2 distance corresponds to a
correlation length of 3.26 µm (K. Ham, private communication). The correlation length relates to
the size of the object responsible for the small angle scatter. This correlation length is of interest,
it was suspected that the high quantities of mitochondria in the BAT would be the source of small
angle scatter but mitochondria are .5-1 µm. It is unclear what was around the size of 3.26 µm that
caused the small angle scatter, creating DF signal.

Table 4.1. Mean pixel values of excised BAT and WAT at various object-to-G2 distance.

4.3.3. Appearance of Intrascapular BAT in DF Images
Due to the motion of the mice in Cohort 1, the 3D reconstructed images were too poor to
use for assessment of DF visualization of BAT. Figure 4.9 shows an axial slice for both absorption
and dark-field of Mouse 2 Cohort 1. In the absorption image, the holder is the outer grey circle,
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the back of the mouse is the top part of the mouse. The highest structures that are white are the
scapula of the mouse, and the lowest white structures are the feet and legs of the mouse. The most
central white object is a spinal vertebra. The dark-field image is so poor that hardly any structures
are discernible. Additionally, the images from Cohort 1 did not have strong contrast between BAT
and WAT signals, calling into question the choice of object-to-G2 distance. For this and the
immobilization issues, the Cohort 1 data were not used for detailed analysis in Chapter 5; only
mice from Cohort 2, which produced reasonable reconstructed images, were used.

Figure 4.8. (left) Dissection to show the intrascapular BAT depots in a mouse. (right) WAT
and BAT samples. The WAT sample is above the BAT sample.
Table 4.1 summarizes the sample preparation and utilization for the Cohort 2 mice. Two
of the mice, which were the first of Cohort 2 to be imaged, didn’t use the improved immobilization
methods, produced poor reconstructed images, and were excluded from detailed analysis. The last
three mice in the Cohort went directly from the cold exposure environment or the control
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environment, without SPECT imaging or freezing, to see if freezing was potentially affecting the
BAT DF signal.
Regions that were the correct size and shape, and in the correct place, for intrascapular fat
depots were seen on Cohort 2 interferometry absorption images. Figure 4.10 and Figure 4.11 show
images for a cold-exposed mouse and a control mouse, respectively. Any fat deposit should be
visible on an absorption images (labeled B,C, and D) because fat exhibits less attenuation due to
its lower density than surrounding muscle; however, no differentiation between white and brown
fat is expected. The absorption images provided a guide to locate the fat deposit in the DF images.

Figure 4.9. For Mouse 2 Cohort 1, transverse slices for absorption (left) and DF (right)
through the expected location of intrascapular BAT. Motion-induced artifacts are
substantial in these images.
The DF images for the cold exposed mice (e.g., Figure 4.10; F,G,H) were visually
compared to the DF images for the control mice (e.g., Figure 4.11; F,G,H). There appeared to be
no substantial visually discernible difference between cold exposed mice and control mice in either
the interferometry absorption or dark field images.

46

There were concerns that freezing the mice might be reducing or interfering with the BAT
dark-field signal. To address this issue, three mice from Cohort 2 were taken directly from coldexposure or control exposure, euthanized, and immediately imaged with the Keck interferometer;
these mice were not imaged with

99m

Tc-sestamibi and thus not frozen during the period of

radioactive decay.

Table 4.2. Cohort 2 data.

4.4. Interferometry Discussion
As with the SPECT results, there was no substantial visual difference in the dark field
images for the intrascapular region between cold exposed and control mice. Aim 3 (Chapter 5)
presents a more quantitative analysis of the DF images.
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The improved sample preparation procedure used for Cohort 2, including shaving the mice
and the additional immobilization techniques, appeared to be effective in terms of visual image
quality. This procedure should be useful for any future ex vivo interferometry imaging of mice.
However, the approach here would not work for in vivo imaging; a non-invasive immobilizer that
could hold a live mouse in a vertical orientation, such as a low-density (foam) molded bed, would
be necessary. For in vivo imaging, integrated anesthesia delivery would also be needed.
One potential limitation of this study is that the distance from the mouse to the G2 grating
provided the largest possible signal for the available curved gratings and their requisite geometry,
but this did not necessarily yield an optimal signal. To achieve an optimal signal, a grating design
and inter-grating distances that are specific to the expected correlation length of BAT would be
necessary. For this pilot project, cost limitations prevented the development of optimized gratings.
The use of the available curved gratings precluded evaluating other inter-grating distances; the
curvature locks the inter-grating distances to a fixed values. Future efforts on DF imaging of BAT
should consider optimization of grating design and inter-grating distances.
Eggl et.al (2015) showed that dark-field interferometry could differentiate between white
and brown fat in a newborn mouse, while our results in adult mice were visually equivocal.
Newborn mice have substantial quantities of active brown fat; the cold-exposure regime likely
does not induce as high of a level of BAT activity. Imaging of newborn mice on the Keck
interferometer would provide a baseline for comparison to Eggl’s work as well to cold-exposed
adult mice. This reevaluation could use an intact infant mouse or simply use BAT and WAT
samples.
Other future work could include looking at female mice, which expressed a different range
of elevated biochemical markers, as well as varying the parameters of the cold exposure regimen,
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such as the duration or temperature. The one week of cold exposure at 8°C was sufficient to
produce a statistically significant increase in BAT activation, seen through UCP1 and other bio
chemical markers. However, this level was not high enough to cause a significant visual change in
DF signal.
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Figure 4.10. Mouse 5 Cohort 2 absorption (top) and dark-field (bottom) images. Each set
of four images shows (A,E) a 3D rendering, (B,F) a transverse slice, (C,G) a coronal
slice, and (D,H) a sagittal slice. Mouse 5 was cold-exposed. The blue arrows point
to the expected location of intrascapular BAT.
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Figure 4.11. Mouse 6 Cohort 2 absorption (top) and dark-field (bottom) images. Each set
of four images shows (A,E) a 3D rendering, (B,F) a transverse slice, (C,G) a coronal
slice, and (D,H) a sagittal slice. Mouse 6 was a 22°C control mouse. The blue
arrows point to the expected location of intrascapular BAT.
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Chapter 5. Aim 3 Correlation
This chapter discusses Aim 3 of the project, which was to quantitatively compare the
SPECT-CT images (Aim 1, Chapter 3) and the x-ray interferometry images (Aim 2, Chapter 4)
between the two sets of mice.
5.1. Correlation Analysis Methods
5.1.1. Masks for SPECT Data
As noted in the previous Aims, the

99m

Tc-MIBI SPECT images and the interferometry

images lacked substantial visual differences between cold exposed and control mice. Region of
interest analysis was used to determine if any quantitative differences exist between cold-exposed
and control mice; this analysis should be more sensitive to small differences between gross
anatomical regions. For this analysis, Avizo 9.0.1 (Thermo Fisher Scientific) was used to manually
contour the SPECT images and the interferometry images. Contouring was performed slice-byslice in each dataset, creating masks representing the 3D anatomical regions. One mask was
generated on the SPECT data for its analysis; a second mask was generated from the interferometry
absorption image for use as a shared mask on both the DF and absorption images. Each mask was
exported from Avizo as a list of voxel coordinates. The SPECT and interferometry images, as well
the corresponding masks, were then loaded into MATLAB (R2020a, MathWorks) to perform the
region-of-interest analysis.
Because of the poor spatial resolution of SPECT images, the masks were generated in
Avizo such that they were defined by the outer body boundary in the transverse dimensions, as
well as boundaries along the mouse’s longitudinal axis set by the intrascapular region where BAT
was expected. Using the outer body boundary excluded spurious “hot” pixels (caused by scattered
radiation or bad pixels in the SPECT detector) from the analysis. This created masks for three
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regions for each mouse, as shown in Figure 5.1: a “head” region (all slices superior to the BAT
slices), a “BAT” region, and an “abdomen/bladder” region (slices inferior to the BAT slices). The
abdomen/bladder region ended at the base of tail, to exclude an area of high radiotracer
accumulation frequently seen in the tail due to the tail vein injection. Note that the head region
included several structures that could have potentially accumulated tracer, such as the parathyroid,
the thyroid, and perhaps a supraclavicular BAT deposit, but these could not be spatially
differentiated on SPECT. Total counts within the three regions were tabulated in Matlab and
compared.

Abdomen/Bladder

BAT

Head

Figure 5.1. Shows the regions of the SPECT-CT images used for analysis.
5.1.2. Masks for Interferometry Data
For the interferomety images, the intrascapular fat deposit was visually distinguishable
from adjacent tissues in the absorption image. A mask of the fat deposit was manually contoured
slice-by-slice on the absorption images for each mouse. Figure 5.2 shows a sample absorption
dataset, while Figure 5.3 shows the resulting mask overlaid on the absorption images.
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Figure 5.2. Absorption images for Mouse 5 Cohort 2. Shown are a 3D rendering (top left),
axial slice (top right), coronal slice (bottom left), and sagittal slice (bottom right).
The fat deposit appears as darker triangular regions in the three orthogonal-slice
views.
The absorption and dark field images, along with the mask file, were loaded into
MATLAB. The values of the voxels in the mask were extracted from the dark field and absorption
images. Following an analysis method from Wen et al. (2008), the voxel values were binned into
a 2D histogram of absorption vs. dark-field. This style of plot shows correlations between the two
image types. For tissues that have similar attenuation, one can see if the DF signals are different,
for instance. If the mask includes a mix of tissue types, such as both BAT and WAT, these should
show up as separate clusters in the histogram if they differ in either absorption or DF.
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Figure 5.3. Absorption images for Mouse 5 Cohort 2, with the BAT mask contoured in
blue. Shown are a 3D rendering (top left), axial slice (top right), coronal slice
(bottom left), and sagittal slice (bottom right). The fat deposit appears as darker
triangular regions in the three orthogonal-slice views.
5.2. Correlation Analysis Results
The results of region-of-interest comparisons between the cold-exposed 8°C mice group
and the control 22°C mice group, for Cohort 2, are presented in this section. The inter-comparisons
were made for each type of imaging method: SPECT, absorption and dark-field.
5.2.1. SPECT Results
Comparisons of the SPECT radiotracer uptake between pairs of regions are shown in
Figure 5.4 (BAT vs. head region), Figure 5.5 (BAT vs. abdomen/bladder), and Figure 5.6 (BAT
vs. whole body, i.e., all three regions together). Straight-line fits to the data are shown. In Figure
5.4, one sees that cold exposed mice generally had higher tracer uptake in BAT than the control
mice. Figure 5.5 shows that in both cold-exposed and control mice, BAT uptake increased at the
same rate as the uptake increased in the abdomen/bladder region.
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Figure 5.4. Comparison of cumulative uptake in BAT vs. head regions for cold-exposed
(8°C) and control (22°C) mice. The fitted lines are 8°C: y = 0.1525x – 18748 and
22°C: y = 0.1028x – 26045.

Figure 5.5. Comparison of cumulative uptake in BAT vs. abdomen/bladder regions for
cold-exposed (8°C) and control (22°C) mice. The fitted lines are 8C:
y = 0.0191x – 20132 and 22C: y = 0.0199x – 31394.

56

Figure 5.6. Comparison of cumulative uptake in BAT vs. all regions combined for coldexposed (8°C) and control (22°C) mice. The fitted lines are 8C:
y = 0.0133x – 9532 and 22C: y = 0.0144x – 2580.
5.2.2. Interferometry
Figure 5.7 shows a representative 2D histogram of absorption vs. DF for the cold-exposed
Mouse 5 Cohort 2. Profiles plotted through the maximum center point of this histogram parallel to
the absorption and dark-field axes are shown in Figure 5.7, respectively. The profiles for all mice
were fitted to a Gaussian function; Table 5.1 provides the fit parameters. Appendix E contains the
histograms, profiles, and fitted profiles for all Cohort 2 mice.
In the 2D histogram, the data points for Mouse 5 Cohort 2 visually appeared to form a
single cluster. The cluster was wider in the absorption direction, showing that the absorption values
varied across a larger range than the DF values. The cluster’s maximum was located at a positive
value on the DF axis, indicating the presence of a dark-field signal (a DF value of zero corresponds
to no small-angle scattering). In both directions, the profiles appeared to be symmetric and fit well
to a single Gaussian function, indicating only a single voxel type is present in the cluster.
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The 2D histograms, profiles, and Gaussian fits for cold-exposed mice and control mice in
Cohort 2 were all visually similar to the example shown for Mouse 5 Cohort 2, with a few
exceptions. The peak of the histogram for Mouse 2, which used bubble wrap for immobilization
rather than suture technique, occurred at a negative DF value which is physically inappropriate.
This may be an indication of how material surrounding the mouse may interfere with DF
measurements (cf. discussion in Ch. 4 about mouse fur). Another exception was the DF profile for
Mouse 17, which exhibited an asymmetric shape (Figure 5.8); this could indicate that a smaller
quantity of voxels in the mask may have belonged to a different type of material, such as bone or
air.
The average and standard deviations of the amplitudes (A), centers () and widths () for
the Gaussian fits are shown in Table 5.1. Comparing between cold-exposed and control groups, a
two-tailed t-test for populations for unequal variances indicated that none of the parameters were
statistically significantly different. The p-values ranged from 0.28 to larger than 0.9. No correction
was made for multiple comparisons because each cold-exposed fit parameter was compared only
to the corresponding parameter of the control group. The parameter that exhibited the smallest pvalue was the center () for absorption images, with p=0.28.
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A

B

C

Figure 5.7. A) Histogram of absorption vs dark-field pixel values for Mouse 5 Cohort 2.
B) Gaussian fit to the absorption profile for Mouse 5 Cohort 2. C) Gaussian fit to
the dark-field profile for Mouse 5 Cohort 2.
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Table 5.1. (upper table) Summary of the fitted parameters for profiles through the peak of
the 2D histograms of absorption vs. dark-field. (bottom tables) Averages and
standard deviations of the fitted parameters for the 8°C and 22°C mice. The
Gaussian fitting function was:

𝐺 (𝑥 ) = 𝐴𝑒
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5.3. Correlation Analysis Discussion
5.3.1. SPECT
The quantitative analysis showed no significant differences for the SPECT data between
the 8°C mice and the 22°C mice. The BAT and abdomen/bladder regions followed nearly identical
trends – as uptake increased in one region, it increased at the same pace in the other. This likely
indicates that the uptake in both regions was caused by the same underlying process;
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Tc-

sestamibi distributes in part according to blood flow [Cardinal Health 414, LLC 2016], so similar
blood flow rates throughout these regions presumably explain the similarity. The BAT region in
8°C mice showed a steeper rate of increase relative to the head region, compared to 22°C mice.
This indicates that the cold-exposure did have an impact, although apparently causing reduced
uptake in the neck region rather than increased uptake in BAT. Possibly, the cold exposure
supressed the physiological activity of the parathyroid, thyroid, or other tissues in this region; this
is a question for experts in cold-adaptation and was not pursued further here.
A possible improvement on this analysis would be to use the CT portion of the SPECT-CT
data to define more organ- or location-specific regions of interest. While this would potentially
refine the analysis to specific organs, the smaller regions of interest would result in more noise in
the radiotracer results. Coupling this refinement to the acquisition of higher-count SPECT data, by
using longer counting times per projection or a high-sensitivity collimator, would offset the noise.
As mentioned previously, another improvement would be to use a different SPECT radiotracer
such as 123I-MIBG or 123I-BMIPP.
5.3.2. Interferometry
The results of the interferometry analysis showed that DF imaging was not able to
differentiate activated BAT in cold-exposed animals from BAT tissue in a control animal. The
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likely explanation is that the cellular components that give rise to the DF signal, i.e., mitochondria
in BAT, are comparable in amounts and distribution between the two groups of animals – coldexposure ramps up the functioning of the mitochondria, but doesn’t change their properties in
terms of small-angle scattering. This indicates that DF imaging was not sensitive to physiological
changes in BAT.
The appearance of a single cluster in the 2D histograms indicated that the cells within the
intrascapular region were principally one cell type, i.e., BAT, rather than mixture of BAT and
WAT (in control animals) or beiged WAT (in cold-exposed animals). The histology images in
Figure 2.2 showed obvious changes in iWAT but not BAT from cold exposure; these changes
(reduction in lipid droplet size and mitochondrial content) should cause a change in DF signal if
they were present. In future work, the analysis should be extended to a WAT deposit elsewhere
in the body, such as in the abdomen; unfortunately, the interferometry acquisitions in this work
focused on the neck region, so a WAT depot may not be accessible in the current image datasets.
Presumably, a mixture of WAT and beiged WAT would result in changes to the center () and/or
width () parameters, or even the appearance of multiple clusters of voxels.
Of the Gaussian fit parameters, the parameter that was closest to statistical significance
was the center () value for absorption images. While not significantly different, this parameter
indicated that BAT in a cold-exposed mouse exhibited somewhat more attenuation than in a
control mouse, generally in agreement with a publication reporting higher CT Hounsfield units in
a presumptive region of BAT in a cold-exposed animal [Baba 2010].
A limitation of the interferometry analysis was the ability to adequately contour the region
of the fat deposit in 3D. The mask was contoured in the axial slices; there were times that it was
hard to distinguish the boundary of the fat depot. In this work, the contour was drawn to exclude
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questionable voxels, ensuring that the mask only covered the fat tissue. While the administration
of CT contrast agents is a common diagnostic method to enhance the appearance of tissues, their
impact on DF signal was not known so contrast enhancement was not pursued.
As mentioned with the SPECT imaging, a possible future avenue to explore is to apply the
interferometry methods and analysis used here to neonatal mice with more substantial BAT depots
[Eggl 2015]. Another piece of future work is to evaluate additional mice that are not frozen
between cold exposure and interferometry imaging. Two of these three mice in this study exhibited
differences. Mouse 17, a control mouse, showed an asymmetric appearance in the Gaussian DF
profile; Mouse 18, a cold-exposed mouse, had the largest center (m) parameter for absorption of
any Cohort 2 specimen. With only three mice in the set that skipped SPECT imaging and freezing,
no conclusions can be made.

Figure 5.8. Mouse 17 Cohort 2 DF gaussian fit to profile of pixel value histogram. The data points
are positively skewed making the gaussian a poor fit. Compare figure 5.9 where the
gaussian fit followed the data points well.
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Chapter 6. Conclusion
Obesity is a rising epidemic with many researchers looking for more ways to help people
to lose weight and maintain their weight loss. Brown adipose tissue may be the answer for many
of these people. BAT is full of mitochondria, which plays a role in heat generation in BAT. BAT
can be activated by environmental stressors or pharmacologic agents, which results in upregulation
of mitochondrial activity. The ability to determine the degree to which BAT is activated is
important for developing BAT as a weight-loss or maintenance tool; unfortunately, the best
quantitative tests require invasive biopsies. While various imaging modalities can visualize BAT
relative to surrounding tissues, no modality has a clear advantage for quantification of BAT in
vivo.
This work investigated if dark-field interferometry imaging could differentiate between
nonactivated and activated BAT; SPECT imaging and biomarkers were used as a reference to
compare to the DF images. DF interferometry imaging is sensitive to small structures such as
mitochondria, so changes in intracellular composition or cell size due to activation could
conceivably alter the DF signal. Mice were put through one week of cold exposure to activate the
BAT. Following the cold exposure one group of mice was euthanized to perform a biochemical
assay of several known genes that are linked to BAT activation. Other mice were imaged by
SPECT-CT and subsequently imaged by DF interferometry.
Biochemical assay demonstrated that the week of cold exposure caused BAT activation in
mice. SPECT imaging with

99m

Tc-sestamibi showed elevated tracer uptake in the intrascapular

BAT, but this uptake was comparable to increases seen elsewhere in the cold-exposed animals.
This indicated that the tracer uptake was not due specifically to BAT activation. The intrascapular
BAT depot was visible against surrounding soft tissue in both absorption and DF images.
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However, no significant change in DF signal magnitude was observed in activated BAT compared
to the same region in the control mice. This indicated that BAT activation did not result in cellular
changes that contribute to small-angle scattering and DF signal, such as increased numbers of
mitochondria or changes in cell size.
Several potential limitations were identified in the work. The SPECT imaging used a
pinhole collimator on the premise that good spatial resolution was desired for imaging of mice; in
retrospect, using a higher sensitivity collimator would be preferred to better measure small
differences in radiotracer uptake in activated BAT. During SPECT imaging, isoflurane was used
as the anesthesia, but isoflurane has been noted to potentially inhibit the activation of BAT [Olsen
2017]. Suppression of BAT activity could explain why the tracer uptake was comparable to other
tissues, rather than elevated. MIBI was chosen because it is known to accumulate in BAT; other
possible tracers were not feasible for this pilot study because they would have required on-site
synthesis (e.g., iodine-labelled tracers) or were not usable with the SPECT system (e.g., 18F-FDG).
Other research has shown that while MIBI accumulates in BAT, it is not as significant as some
other tracers in activated BAT [Baba 2007].
The principally limitation of the interferometer system was tuning to the desired length
scale for BAT. This pilot project used existing gratings which were not specifically designed for
optimum visualization of BAT. The only available tuning parameter was the object to G2 distance,
so the best achievable tuning of the interferometer may still have been suboptimal for BAT.
Designing the gratings and interferometer geometry specifically for BAT produce better results.
A limitation of the interferometry analysis was adequate contouring of the intrascapular BAT
region in the 3D reconstructions. Contouring was done manually by a user with limited knowledge
of mouse anatomy. Better contouring of the BAT as well as accurate contouring of other

65

anatomical regions could enable analysis of other adipose tissues, such as regions where beiged
WAT might be found.
This work could be extended in several ways. SPECT imaging was only intended as an
independent means to confirm the location of activated BAT; radiotracer assessment of BAT was
not a primary goal of this work. With that said, future continuation of this work should use a
higher-sensitivity collimator, such as a parallel hole collimator for SPECT imaging. Likewise,
consideration should be given to other tracers, as discussed in Chapter 3.
Another possible avenue to explore is whether, assuming the interferometry methods and
analysis used here were sound, the cold-exposure process was simply unable to generate sufficient
BAT activity in these mice (chosen because they are a common model for obesity research).
Neonatal mice and/or other strains such as nude mice can exhibit more substantial BAT depots,
which may be easier to image with DF interferometry. Finally, the analysis in this project focused
only on the intrascapular BAT region, although the image data potentially encompassed other
BAT, WAT and beiged WAT depots. These other regions should be investigated in the available
data to assess the ability of DF interferometry to quantify differences in beiged WAT compared to
control mice. Histological sections showed apparent changes in cell size for some WAT samples;
this type of change in cell structure is something for which DF interferometry could be applicable.
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Appendix A. Planar Images
This Appendix contains the planar SPECT images used to create the time-activity curves.

Figure A.1. Mouse 1 Cohort 2 planar images.

Figure A.2. Mouse 2 Cohort 2 planar images.
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Figure A.3. Mouse 3 Cohort 2 planar images.
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Appendix B. SPECT-CT Images
This Appendix contains the SPECT-CT images of both cohorts of mice.

Figure B.1. SPECT-CT Mouse 2 Cohort 1. SPECT data was normalized by injected activity (467.4
µCi) at the start of image acquisition. This mouse was kept at 24°C for one week before
imaging.
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Figure B.2. SPECT-CT Mouse 4 Cohort 1. SPECT data was normalized by injected activity (851.3
µCi) at the start of image acquisition. This mouse was kept at 24°C for one week before
imaging.
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Figure B.3. SPECT-CT Mouse 5 Cohort 1. SPECT data was normalized by injected activity (810.8
µCi) at the start of image acquisition. This mouse was kept at 8°C for one week before
imaging.
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Figure B.4. SPECT-CT Mouse 6 Cohort 1. SPECT data was normalized by injected activity (722.0
µCi) at the start of image acquisition. This mouse was kept at 24°C for one week before
imaging.
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Figure B.5. SPECT-CT Mouse 8 Cohort 1. SPECT data was normalized by injected activity (717.4
µCi) at the start of image acquisition. This mouse was kept at 8°C for one week before
imaging.
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Figure B.6. SPECT-CT Mouse 9 Cohort 1. SPECT data was normalized by injected activity (545.8
µCi) at the start of image acquisition. This mouse was kept at 8°C for one week before
imaging.
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Figure B.7. SPECT-CT Mouse 10 Cohort 1. SPECT data was normalized by injected activity
(707.9 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.8. SPECT-CT Mouse 11 Cohort 1. SPECT data was normalized by injected activity
(768.8 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.9. SPECT-CT Mouse 12 Cohort 1. SPECT data was normalized by injected activity
(789.8 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.

77

Figure B.10. SPECT-CT Mouse 5 Cohort 2. SPECT data was normalized by injected activity
(739.7 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.11. SPECT-CT Mouse 6 Cohort 2. SPECT data was normalized by injected activity
(752.4 µCi) at the start of image acquisition. This mouse was kept at 24°C for one week
before imaging.
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Figure B.12. SPECT-CT Mouse 7 Cohort 2. SPECT data was normalized by injected activity
(918.4 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.13. SPECT-CT Mouse 8 Cohort 2. SPECT data was normalized by injected activity
(779.5 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.14. SPECT-CT Mouse 9 Cohort 2. SPECT data was normalized by injected activity
(1052.2 µCi) at the start of image acquisition. This mouse was kept at 24°C for one week
before imaging.
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Figure B.15. SPECT-CT Mouse 10 Cohort 2. SPECT data was normalized by injected activity
(362.6 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.16. SPECT-CT Mouse 11 Cohort 2. SPECT data was normalized by injected activity
(971.1 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.17. SPECT-CT Mouse 12 Cohort 2. SPECT data was normalized by injected activity
(656.4 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.18. SPECT-CT Mouse 13 Cohort 2. SPECT data was normalized by injected activity
(758.9 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.19. SPECT-CT Mouse 14 Cohort 2. SPECT data was normalized by injected activity
(1083.5 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Figure B.20. SPECT-CT Mouse 15 Cohort 2. SPECT data was normalized by injected activity
(1073.3 µCi) at the start of image acquisition. This mouse was kept at 8°C for one week
before imaging.
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Appendix C. Interferometry Absorption Images
This Appendix contains the interferometry absorption images of the second cohort of mice.

Figure C.1. Interferometry absorption image Mouse 2 Cohort 2. This mouse went through the cold
exposure.
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Figure C.2. Interferometry absorption image Mouse 3 Cohort 2. This mouse went through the cold
exposure.
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Figure C.3. Interferometry absorption image Mouse 5 Cohort 2. This mouse went through the cold
exposure.
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Figure C.4. Interferometry absorption image Mouse 6 Cohort 2. This mouse did not go through
the cold exposure.
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Figure C.5. Interferometry absorption image Mouse 7 Cohort 2. This mouse went through the cold
exposure.
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Figure C.6. Interferometry absorption image Mouse 8 Cohort 2. This mouse went through the cold
exposure.
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Figure C.7. Interferometry absorption image Mouse 9 Cohort 2. This mouse did not go through
the cold exposure.
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Figure C.8. Interferometry absorption image Mouse 10 Cohort 2. This mouse went through the
cold exposure.
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Figure C.9. Interferometry absorption image Mouse 11 Cohort 2. This mouse went through the
cold exposure.
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Figure C.10. Interferometry absorption image Mouse 12 Cohort 2. This mouse went through the
cold exposure.
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Figure C.11. Interferometry absorption image Mouse 13 Cohort 2. This mouse went through the
cold exposure.
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Figure C.12. Interferometry absorption image Mouse 14 Cohort 2. This mouse went through the
cold exposure.
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Figure C.13. Interferometry absorption image Mouse 15 Cohort 2. This mouse went through the
cold exposure.
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Figure C.14. Interferometry absorption image Mouse 16 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Figure C.15. Interferometry absorption image Mouse 17 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Figure C.16. Interferometry absorption image Mouse 18 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Appendix D. Interferometry Dark Field Images
This Appendix contains the interferometry dark field images of the second cohort of mice.

Figure D.1. Interferometry dark-field image Mouse 2. This mouse went through the cold exposure.
This mouse wasn’t shaved.
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Figure D.2. Interferometry dark-field image Mouse 3. This mouse went through the cold exposure.
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Figure D.3. Interferometry dark-field image Mouse 5. This mouse went through the cold exposure.
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Figure D.4. Interferometry dark-field image Mouse 6. This mouse did not go through the cold
exposure.
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Figure D.5. Interferometry dark-field image Mouse 7 Cohort 2. This mouse went through the cold
exposure.
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Figure D.6. Interferometry dark-field image Mouse 8 Cohort 2. This mouse went through the cold
exposure.
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Figure D.7. Interferometry dark-field image Mouse 9 Cohort 2. This mouse did not go through the
cold exposure.
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Figure D.8. Interferometry dark-field image Mouse 10 Cohort 2. This mouse went through the cold
exposure.
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Figure D.9. Interferometry dark-field image Mouse 11 Cohort 2. This mouse went through the cold
exposure.
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Figure D.10. Interferometry dark-field image Mouse 12 Cohort 2. This mouse went through the
cold exposure.
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Figure D.11. Interferometry dark-field image Mouse 13 Cohort 2. This mouse went through the
cold exposure.
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Figure D.12. Interferometry dark-field image Mouse 14 Cohort 2. This mouse went through the
cold exposure.
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Figure D.13. Interferometry dark-field image Mouse 15 Cohort 2. This mouse went through the
cold exposure.
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Figure D.14. Interferometry dark-field image Mouse 16 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Figure D.15. Interferometry dark-field image Mouse 17 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Figure D.16. Interferometry dark-field image Mouse 18 Cohort 2. This mouse went through the
cold exposure but, was never frozen.
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Appendix E. Absorption versus Dark Field Histograms
These are the histograms created by comparing absorption to dark field pixel values. This
appendix also has the gaussian fits to the absorption and dark-field profile. Gaussian fit parameters
can be found in table 5.1.

Figure E.1. Histogram of dark-field pixel values vs absorption values for Mouse 2 Cohort 2.
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Figure E.2. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 2 Cohort 2.
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Figure E.3. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 2 Cohort 2.
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Figure E.4. Histogram of dark-field pixel values vs absorption values for Mouse 3 Cohort 2.
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Figure E.5. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 3 Cohort 2.
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Figure E.6. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 3 Cohort 2.
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Figure E.7. Histogram of dark-field pixel values vs absorption values for Mouse 5 Cohort 2.
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Figure E.8. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 5 Cohort 2.
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Figure E.9. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 5 Cohort 2.
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Figure E.10. Histogram of dark-field pixel values vs absorption values for Mouse 6 Cohort 2.
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Figure E.11. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 6 Cohort 2.
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Figure E.12. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 6 Cohort 2.
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Figure E.13. Histogram of dark-field pixel values vs absorption values for Mouse 7 Cohort 2.
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Figure E.14. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 7 Cohort 2.
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Figure E.15. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 7 Cohort 2.
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Figure E.16.. Histogram of dark-field pixel values vs absorption values for Mouse 8 Cohort 2.
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Figure E.17. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 8 Cohort 2.
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Figure E.18. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 8 Cohort 2.
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Figure E.19. Histogram of dark-field pixel values vs absorption values for Mouse 9 Cohort 2.

139

Figure E.20. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 9 Cohort 2.
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Figure E.21. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 9 Cohort 2.
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Figure E.22. Histogram of dark-field pixel values vs absorption values for Mouse 10 Cohort 2.
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Figure E.23. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 10 Cohort 2.
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Figure E.24. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 10 Cohort 2.
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Figure E.25. Histogram of dark-field pixel values vs absorption values for Mouse 11 Cohort 2.
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Figure E.26. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 11 Cohort 2.
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Figure E.27. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 11 Cohort 2.
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Figure E.28. Histogram of dark-field pixel values vs absorption values for Mouse 12 Cohort 2.
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Figure E.29. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 12 Cohort 2.
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Figure E.30. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 12 Cohort 2.
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Figure E.31. Histogram of dark-field pixel values vs absorption values for Mouse 13 Cohort 2.
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Figure E.32. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 13 Cohort 2.
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Figure E.33. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 13 Cohort 2.
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Figure E.34. Histogram of dark-field pixel values vs absorption values for Mouse 14 Cohort 2.
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Figure E.35. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 14 Cohort 2.
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Figure E.36. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 14 Cohort 2.
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Figure E.37. Histogram of dark-field pixel values vs absorption values for Mouse 15 Cohort 2.
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Figure E.38. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 15 Cohort 2.
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Figure E.39. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 15 Cohort 2.
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Figure E.40. Histogram of dark-field pixel values vs absorption values for Mouse 16 Cohort 2.
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Figure E.41. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 16 Cohort 2.
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Figure E.42. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 16 Cohort 2.

162

Figure E.43. Histogram of dark-field pixel values vs absorption values for Mouse 17 Cohort 2.
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Figure E.44. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 17 Cohort 2.
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Figure E.45. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 17 Cohort 2.
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Figure E.46. Histogram of dark-field pixel values vs absorption values for Mouse 18 Cohort 2.
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Figure E.47. Absorption profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 18 Cohort 2.
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Figure E.48. Dark-field profile through the max of the histogram of dark-field pixel values vs
absorption values for Mouse 18 Cohort 2.
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